Cited in 5 publications. View NanoLuc® (Nluc) Luciferase Antibody (MAB10026) validated in Multi-Species. Additional non-catalog clones available.
新品发布NEWAnti-HiBiT Monoclonal AntibodyHiBiT是一种11个氨基酸的多肽标签,使用NanoLuc Binary Technology(或称为NanoBiT)可以简单,灵敏地定量标记的蛋白质。其与大亚基(LgBiT)互补,可重组成明亮的萤光素酶,促进蛋白质动力学的测定,包括表达水平、降解、易位和翻译后修饰。为了将HiBiT的功能扩展到包括传统的免疫测定,...
Baatartsogt, N. et al. A sensitive and reproducible cell-based assay via secNanoLuc to detect neutralizing antibody against adeno-associated virus vector capsid. Mol. Ther. - Methods Clin. Dev. 22, 162–171 (2021).
Anti-HiBiT Monoclonal Antibody n7200 N7210 使用说明书 2023版 CTM719原英文技术手册 TM719 中 文 说 明 书 适用产品目录号：N7200、N7210 Anti-HiBiT Monoclonal Antibody
Baatartsogt, N. et al. A sensitive and reproducible cell-based assay via secNanoLuc to detect neutralizing antibody against adeno-associated virus vector capsid. Mol. Ther. - Methods Clin. Dev. 22, 162–171 (2021).
The nanoluc luciferase severe respiratory syndrome coronavirus 2 (SARS-CoV-2-Nluc) established in our previous study29 was used to evaluate the involvement of identified host factors in viral entry and replication. Experiments with SARS-CoV-2 and nano-Luciferase virion were performed in a BSL-3 ...
A human non-small-cell lung cancer (NSCLC) cell line stably expressing NanoLuc reporter (Nluc-H1915) was inoculated from the internal carotid artery of SCID mice. After metastases were established (24days after inoculation), splenocytes prepared from H1915-immunized BALB/c mice were injected ...
(n = 3) mixed at a ratio of 2:1 in a total volume of 100 μl on day 0. NanoLuc luciferase expression was measured by i.v. injection of 5 μl of substrate (Promega) in 100 μl PBS solution into the lateral tail vein on day 3 and imaged using the NightOWL in vivo...
Table S1. Antibody variable gene region sequences for E1 antibodies, related to Figure 1 Table S2. Mapping of CHIKV E1 mouse mAbs by alanine-scanning mutagenesis, related to Figure 2 Table S3. Mapping of DC2.112 and DC2.315 mAbs by alanine-scanning mutagenesis, related to Figure 2 Table S4...
Abnormal tumour vasculature has a significant impact on tumour progression and response to therapy. Nitric oxide (NO) regulates angiogenesis and maintains vascular homeostasis and, thus, can be delivered to normalize tumour vasculature. However, a NO-del